Virpax Pharmaceuticals (VRPX) Short Interest Ratio & Short Volume $0.34 +0.01 (+3.03%) (As of 05:45 PM ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Virpax Pharmaceuticals Short Interest DataVirpax Pharmaceuticals (VRPX) has a short interest of 240,400 shares, representing 3.09% of the float (the number of shares available for trading by the public). This marks a -37.80% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 2.45 million shares to cover all short positions.Current Short Interest240,400 sharesPrevious Short Interest386,500 sharesChange Vs. Previous Month-37.80%Dollar Volume Sold Short$96,160.00Short Interest Ratio0.1 Days to CoverLast Record DateDecember 15, 2024Outstanding Shares4,888,000 sharesFloat Size7,790,000 sharesShort Percent of Float3.09%Today's Trading Volume1,166,870 sharesAverage Trading Volume2,452,333 sharesToday's Volume Vs. Average48% Short Selling Virpax Pharmaceuticals? Sign up to receive the latest short interest report for Virpax Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartVRPX Short Interest Over TimeVRPX Days to Cover Over TimeVRPX Percentage of Float Shorted Over Time Ad Brownstone ResearchMan Who Called Nvidia Says: “Your Retirement Is Inside This Building.”In 2016, Jeff Brown called Nvidia at a split-adjusted 66 cents. The company just became the world's third $3 trillion company... And the stock is up massively since Jeff's recommendation. Now, Jeff has found five under-the-radar stocks which could power your retirement. Virpax Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 12/15/2024240,400 shares $96,160.00 -37.8%3.1%0.1 $0.40 11/30/2024386,500 shares $178,176.50 +22.7%5.1%0.1 $0.46 11/15/2024315,000 shares $193,473.00 -10.2%4.2%0.1 $0.61 10/31/2024350,900 shares $257,209.70 -38.0%7.6%1.2 $0.73 10/15/2024565,500 shares $249,951.00 +46.7%12.3%1.5 $0.44 9/30/2024385,600 shares $267,760.64 -7.2%8.4%0.1 $0.69 Get the Latest News and Ratings for VRPX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Virpax Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 9/15/2024415,300 shares $344,034.52 -20.6%9.1%0.1 $0.83 8/31/2024523,200 shares $426,512.64 +241.1%11.4%0.1 $0.82 8/15/2024153,400 shares $130,236.60 -42.9%3.3%0 $0.85 7/31/2024268,400 shares $327,448.00 -57.5%6.2%0 $1.22 7/15/2024631,600 shares $675,812.00 +1,625.7%14.8%0.1 $1.07 6/30/202436,600 shares $18,933.18 +28.4%1.5%0 $0.52 6/15/202428,500 shares $19,531.05 -49.7%1.2%0.2 $0.69 5/31/202456,700 shares $39,690.00 -28.8%2.8%0.6 $0.70 5/15/202479,600 shares $62,088.00 +907.6%5.1%0.9 $0.78 4/30/20247,900 shares $21,409.00 -46.6%0.9%0.3 $2.71 4/15/202414,800 shares $52,248.44 -50.3%1.7%0.6 $3.53 3/31/202429,800 shares $126,983.76 +24.7%3.4%1.3 $4.26 3/15/202423,900 shares $99,663.00 +119.3%2.8%1 $4.17 2/29/202410,900 shares $33,266.80 -82.5%1.3%0.3 $3.05 2/15/202462,400 shares $22,938.24 -12.2%0.7%0.2 $0.37 1/31/202471,100 shares $23,391.90 +38.1%0.8%0.2 $0.33 1/15/202451,500 shares $13,750.50 -44.1%0.6%0.2 $0.27 12/31/202392,100 shares $29,481.30 +479.3%1.1%0.3 $0.32 12/15/202315,900 shares $6,224.85 -58.4%0.2%0.1 $0.39 11/30/202338,200 shares $15,272.36 -30.3%0.4%0.7 $0.40 11/15/202354,800 shares $40,661.60 -8.8%0.6%2.1 $0.74 10/31/202360,100 shares $42,983.52 +110.1%0.7%2.4 $0.72 10/15/202328,600 shares $23,457.72 -40.3%0.3%1.1 $0.82 9/30/202347,900 shares $38,315.21 +197.5%0.6%2.3 $0.80 9/15/202316,100 shares $12,702.90 -37.6%0.2%0.7 $0.79 8/31/202325,800 shares $22,188.00 -22.8%0.3%0.8 $0.86 8/15/202333,400 shares $29,893.00 -20.1%0.4%1 $0.90 7/31/202341,800 shares $37,202.00 +1.7%0.5%1.3 $0.89 7/15/202341,100 shares $40,278.00 -48.1%0.5%1.3 $0.98 6/30/202379,200 shares $85,536.00 +56.8%0.9%2.6 $1.08 6/15/202350,500 shares $46,460.00 -35.2%0.6%1.8 $0.92 5/31/202377,900 shares $61,143.71 -26.1%0.9%4.2 $0.78 5/15/2023105,400 shares $90,654.54 +22.3%1.2%6.1 $0.86 4/30/202386,200 shares $61,245.10 +2.9%1.0%4.1 $0.71Stunning Trump Exec Order Leaked (Ad)This secret document contains stunning details about Donald Trump’s very first order of business… the minute he steps back into the White House. Because if what’s in this leaked document is even half true (and trust me, it comes from a very, very credible source)... I put all the details together for you here — but please hurry. 4/15/202383,800 shares $64,291.36 -7.7%1.0%2.1 $0.77 3/31/202390,800 shares $71,278.00 +7.3%1.0%2.3 $0.79 3/15/202384,600 shares $67,680.00 +6.8%1.0%1.8 $0.80 2/28/202379,200 shares $74,677.68 -40.4%0.9%1.6 $0.94 2/15/2023132,900 shares $145,339.44 +285.2%1.6%2.6 $1.09 1/31/202334,500 shares $34,148.10 +1.8%0.4%0.7 $0.99 1/15/202333,900 shares $28,137.00 -18.9%0.4%0.9 $0.83 12/30/202241,800 shares $26,012.14 -51.1%0.5%1 $0.62 12/15/202285,400 shares $68,320.00 +100.9%1.0%2.3 $0.80 11/30/202242,500 shares $35,700.00 +21.1%0.5%1.2 $0.84 11/15/202235,100 shares $30,105.27 +19.0%0.4%1 $0.86 10/31/202229,500 shares $31,565.00 +16.6%0.3%0.7 $1.07 10/15/202225,300 shares $27,071.00 -39.3%0.3%0.5 $1.07 9/30/202241,700 shares $49,623.00 +37.6%0.5%0.9 $1.19 9/15/202230,300 shares $39,693.00 +5.6%0.4%0.6 $1.31 8/31/202228,700 shares $36,449.00 -22.9%0.3%0.5 $1.27 8/15/202237,200 shares $62,496.00 -45.7%0.4%0.6 $1.68 7/31/202268,500 shares $104,120.00 +78.9%0.8%0.8 $1.52 7/15/202238,300 shares $62,046.00 -41.1%0.5%0.3 $1.62 6/30/202265,000 shares $109,200.00 -15.1%0.8%0.4 $1.68 6/15/202276,600 shares $107,240.00 -12.6%0.9%0.5 $1.40 5/31/202287,600 shares $124,392.00 -35.0%1.0%0.5 $1.42 5/15/2022134,800 shares $180,632.00 +61.8%1.5%0.8 $1.34 4/30/202283,300 shares $147,441.00 +1.0%1.0%0.5 $1.77 4/15/202282,500 shares $165,825.00 +32.4%0.9%0.6 $2.01 3/31/202262,300 shares $138,306.00 +3.2%0.7%0.4 $2.22 3/15/202260,400 shares $121,404.00 -4.9%0.7%0.3 $2.01 2/28/202263,500 shares $137,795.00 +15.9%0.7%0.1 $2.17 2/15/202254,800 shares $126,588.00 -22.6%0.6%0.1 $2.31 1/31/202270,800 shares $150,804.00 +17.8%0.8%0.1 $2.13 1/15/202260,100 shares $172,487.00 -70.4%0.7%0.1 $2.87 12/31/2021203,000 shares $696,290.00 -30.7%N/A0.2 $3.43 12/15/2021293,000 shares $1.13 million +222.0%3.3%0.3 $3.85 11/30/202191,000 shares $425,880.00 -60.5%1.0%0.1 $4.68 11/15/2021230,100 shares $991,731.00 -3.6%2.6%0.2 $4.31 10/29/2021238,800 shares $998,184.00 +8.2%2.7%0.1 $4.18 10/15/2021220,700 shares $988,736.00 -25.2%2.5%0 $4.48 9/30/2021294,900 shares $1.42 million -11.1%3.3%0.1 $4.80 9/15/2021331,600 shares $2.00 million +35.2%6.8%0.1 $6.02 8/31/2021245,200 shares $4.68 million +103.8%11.9%0 $19.10 8/13/2021120,300 shares $544,959.00 No Change5.8%0 $4.53 VRPX Short Interest - Frequently Asked Questions What is Virpax Pharmaceuticals' current short interest? Short interest is the volume of Virpax Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of December 15th, investors have sold 240,400 shares of VRPX short. 3.09% of Virpax Pharmaceuticals' shares are currently sold short. Learn More on Virpax Pharmaceuticals' current short interest. What is a good short interest percentage for Virpax Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.09% of Virpax Pharmaceuticals' floating shares are currently sold short. Is Virpax Pharmaceuticals' short interest increasing or decreasing? Virpax Pharmaceuticals saw a drop in short interest in the month of December. As of December 15th, there was short interest totaling 240,400 shares, a drop of 37.8% from the previous total of 386,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Virpax Pharmaceuticals' float size? Virpax Pharmaceuticals currently has issued a total of 4,888,000 shares. Some of Virpax Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Virpax Pharmaceuticals currently has a public float of 7,790,000 shares. How does Virpax Pharmaceuticals' short interest compare to its competitors? 3.09% of Virpax Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Virpax Pharmaceuticals: GRI Bio, Inc. (3.49%), Adial Pharmaceuticals, Inc. (0.91%), ABVC BioPharma, Inc. (5.64%), Ainos, Inc. (6.09%), Virax Biolabs Group Limited (2.20%), GT Biopharma, Inc. (0.70%), CNS Pharmaceuticals, Inc. (2.33%), Galecto, Inc. (2.13%), Alzamend Neuro, Inc. (1.21%), Edesa Biotech, Inc. (0.91%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.32 billion), Spotify Technology S.A. ($4.06 billion), Canadian Natural Resources Limited ($3.45 billion), Reddit, Inc. ($2.79 billion), International Paper ($2.70 billion), Cencora, Inc. ($2.27 billion), SoFi Technologies, Inc. ($2.21 billion), Lululemon Athletica Inc. ($2.13 billion), and Rivian Automotive, Inc. ($2.05 billion). View all of the most shorted stocks. What does it mean to sell short Virpax Pharmaceuticals stock? Short selling VRPX is an investing strategy that aims to generate trading profit from Virpax Pharmaceuticals as its price is falling. VRPX shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Virpax Pharmaceuticals? A short squeeze for Virpax Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of VRPX, which in turn drives the price of the stock up even further. How often is Virpax Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including VRPX, twice per month. The most recent reporting period available is December, 15 2024. More Short Interest Resources from MarketBeat Related Companies GRI Short Squeeze ADIL Short Squeeze ABVC Short Squeeze AIMD Short Squeeze VRAX Short Squeeze GTBP Short Squeeze CNSP Short Squeeze GLTO Short Squeeze ALZN Short Squeeze EDSA Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:VRPX) was last updated on 12/26/2024 by MarketBeat.com Staff From Our PartnersURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored“AI Killer” 10x More Powerful Than ChatGPTElon Musk may be about to “kill” the world’s most powerful AI. Very few people are talking about the one AI...Paradigm Press | SponsoredElon Musk could help pay for your retirementElon Musk is the richest man in the world... And he's pouring trillions into a unique investment.Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virpax Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Virpax Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
